Skip to main content

dargistotug

Generic: Dargistotug

dargistotug: 1 clinical trial tracked.

dargistotug evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about dargistotug, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (1)

A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley)

NCT05327530Registry updated 2026-09-28·Phase 2
Active, not recruiting

Primary endpoint: Progression-Free Survival (PFS) According to Response Evaluation Criteria in Solid Tumors (RECIST Version 1.1) Assessed by Investigator - Avelumab + Sacituzumab Govitecan Versus Avelumab Monotherapy (Avelumab [Control Group] + JB 100 [External Control])

InterventionalRandomizedopen256 enrolledStarted 2022-08Completion 2027-0198 sites · Australia, Belgium, Canada, France…EMD Serono Research & Development Institute, Inc.